EuropaWire | The European Union's press release distribution & ne...

Sanofi Highlights Potential of Lunsekimig as New Treatment Option Following Strong Phase 2 Study Outcomes
(IN BRIEF) Sanofi has announced positive phase 2 clinical results for lunsekimig, a novel bispecific therapy targeting key inflammatory pathways in respiratory diseases. The treatment successfully met primary and key secondary endpoints in studies involving...

How can children use digital media in an autonomous but safe way?
(IN BRIEF) An international group of experts is advocating for a new approach to digital safety for children and adolescents, emphasizing improved platform design over blanket social media bans. Published in Science, the research highlights how recent...

University of Warwick Strengthens Global Leadership in Travel Writing Research with Major Donation and Rare Book Collection
(IN BRIEF) The University of Warwick has received a £1 million donation and a significant collection of rare travel books from philanthropist Bill Newlin, establishing the Bill Newlin Collection and enhancing its leadership in travel-writing research...

Syngenta Expands Crop Protection Portfolio with Breakthrough Solution for Resistant Weeds in Soybean and Cotton
(IN BRIEF) Syngenta has launched VIRESTINA™ technology, a new herbicide solution designed to control resistant grass weeds in soybean and cotton, marking the first major breakthrough of its kind in nearly 40 years. Initially approved in Argentina, the...